Loading clinical trials...
Loading clinical trials...
The MED-EL EAS Extended Follow-up Study is an extended follow-up of the subjects who were enrolled in the pivotal study to assess long-term safety and device performance.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Med-El Corporation
NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more
NCT06058767 · Hearing Loss, Hearing Disorders in Children, and more
NCT06268340 · Hearing Loss, Sensorineural, Severe-to-profound Hearing Loss
NCT06560918 · Hearing Loss, Sensorineural
NCT05414903 · Vestibular Disorder, Hearing Loss, Sensorineural
Stanford Unversity
Palo Alto, California
University of Miami
Miami, Florida
University of Kansas University Medical Center
Kansas City, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions